INTRODUCTION {#s1}
============

The frequent occurrence of human autoimmune diseases has effect on 5% of worldwide population, and it's an increasing burden of morbidity and mortality on human beings. Autoimmune diseases are defined as diseases which an immune response occurred in the host body against autologous tissues and a pathological state of the host tissue damage as to lack of self-tolerance. Autoimmune diseases may arise in certain organs or particular tissues in different places, where are targeted by tissue-specific antigens, or may also involve whole-body tissues simultaneously, which have effect on multiple tissues and are targeted by all kinds of ubiquitously expressed autoantigens. Most of them are more common in females, and involve offspring trending genetics. Generally, the course of disease is long and more protracted chronic, and the pathological mechanism is not clear \[[@R1]\].

The expressions of disease-related genes are changed by environments controlling to altering epigenetic regulatory mechanism of gene expression. The correlation between autoimmune diseases and gene expression is defined as the basis of pathological mechanism . For example, the level of Foxp3 gene expression in the autoimmune diseases patients is lower than the normal \[[@R2]\]. Researchers also found many epigenetics factors (e.g. DNA methylation, microRNA (miRNA) and so on) related with autoimmune diseases. Richardson etc. discovered that DNA methylation is the key to maintain T-cell function. The failure of maintaining methylation levels and patterns in mature T-cell may result in autoreactive and autoimmunity. Lots of newly discovered miRNA regulation involves in innate and adaptive immune responses, immune cell development, T-cell stability and function, and differential miRNA expression specifically \[[@R3]\].

Autoimmune diseases share several diseases mechanism as a result they may have same (or similar) characteristics or same (or similar) etiologies. Recently, Tim-4 was found as a dysregulation in many autoimmune diseases \[[@R4]\]. Hironori's researches also found polymorphisms of CTLA4, as primary susceptibility loci CTLA4 impact on the expression level of alternative splice of negative regulatory elements in T lymphocyte cell immune response \[[@R5]\]. Autoimmune diseases may often occur as overlap that two or more appeared on the same patient \[[@R6]\]. Autoimmune diseases have a genetic predisposition to family that autoimmune diseases family members are more likely to suffer from autoimmune diseases than non-family members, and they may suffer from different types of autoimmune diseases. However, several different autoimmune diseases show the same phenotypic characteristics such as multiple sclerosis and antiphospholipid syndrome, which are defined as neurological disorders and have similar clinical manifestations. The phenomenon of "overlap" and "familial aggregation" adumbrates the necessary link among autoimmune diseases, while autoimmune diseases are also characterized by themselves with showing different clinical phenotypes. Therefore the research of generality and specificity among autoimmune diseases is considered as a breakthrough for studying the pathogenesis of autoimmune diseases.

Autoimmune diseases are not given rise by a single factor and they are caused by a series of inducements, molecules, cellular pathways, phenotypes and events. Autoimmune diseases result from a complex alternate effect of pathways and phenotypes, which initially allow to begin from autoreactivity to manifest, then an initiating event of autoreaction, and finally allow development of self-sustaining tissue damage \[[@R7]\]. Recent researches have identified several risk pathways associated with the four common autoimmune diseases, such as immune response pathways, signaling pathways, transcriptional regulatory pathways, metabolic pathways and so on \[[@R8]\]. P53/p21 pathway and interferon pathway have been affirmed associated with SLE . Genome-wide data research conducted by our team had found 9 risk pathways related with RA, including focal adhesion, extracellular matrix-receptor interaction, calcium signaling, dopaminergic synapse, long-term potentiation, retrograde endocannabinoid signaling, glutamatergic synapse, cholinergic synapse and morphine addiction \[[@R8]\]. Analysis of disease-related risk pathways may help for understanding the pathogenesis of these diseases.

Currently, more than 80 autoimmune diseases have effect on approximately 100 million people worldwide \[[@R9]\], and among these diseases T1D, MS, RA and SLE are more common and more investigative. In summary, the significance of this research is to study the shared and specific characteristics of the four diseases by analyzing the shared and specific pathways and discovering the shared and specific pathological mechanism based on systems biology, that through integrating data of genetic level (such as expression profiling, SNP) and epigenetic level (such as methylation, miRNA), to mine disease-related genes.

RESULTS {#s2}
=======

Four related-disease genes {#s2_1}
--------------------------

We conducted different genes researches on three different types' data (see method), and found significantly different genes in every research ([Supplementary Table 2](#SD1){ref-type="supplementary-material"}). Among the 70 groups of case-control data on different diseases, there was one group that the number of different genes is greater than 1500, 6 groups between 1000 and 1500, and the others less than 1000. We merged the significantly different genes of three different types of data of each disease as a disease-related gene set. That is, the different genes above results calculated union on each type of data of every disease which is defined as the candidate gene sets. Then, we merged with a collection on genes of different types' data with each disease that defined as disease-related candidate gene sets. Finally, we compared four diseases candidate gene set with disease-related gene databases existed to supple genes, which defined as disease-related gene sets (Table [2](#T2){ref-type="table"}). The results contained different genes of methylation, mRNA and miRNA and target genes mapping the three-disease-associated SNP database (RADB <http://www.bioapp.org/RADB/>, TiDbase <https://www.t1dbase.org/page/Welcome/display>, MSGene <http://www.msgene.org/>) and four diseases related to genes that are validated from GAD (<http://geneticassociationdb.nih.gov/>).

These four autoimmune diseases share a familial genetic tendency, while they have different clinical manifestations. In order to understand the shared genetic tendency and specific clinical phenotypes, in our research we found out expression and regulation genes related to these diseases, and analyzed the shared and specific disease-related pathways.

Shared genes and GO terms {#s2_2}
-------------------------

According to the four related-disease genes above, we calculated the intersection of the four sets and obtain 33 genes the four diseases shared (Table [3](#T3){ref-type="table"}). For instance, MIF (macrophage migration inhibitory factor) is a macrophage migration inhibitory factor, also it is a glycosylated inhibitor, and it related with immunoreaction of immune system. Calandra etc. research found that MIF is an important part of the body's antimicrobial alarm system and immune cell proinflammatory function stress \[[@R13]\]. MIF is the constituent component of constituting inflammatory and it is the pathogenesis of autoimmune diseases \[[@R13]\]. Also, TGFB1 (transforming growth factor, beta 1) is a polypeptide of cytokine transforming growth factor involved in cell growth, cell proliferation, cell differentiation and apoptosis. TGFB1 produces and controls immune cells by lymphocytes, macrophages and dendritic cells, and thus it becomes an important component on the pathogenesis of autoimmune diseases \[[@R14]\].In order to further understand the function of these genes and the relationship between them and the four diseases and also to explore the pathogenesis of the diseases, we used the online annotation tool DAVID (<https://david.ncifcrf.gov/>).

We conducted these genes analyzing GO functional annotation, 27 genes were annotated in GO's biological process (BP) branch which showed they are enriched in the immune response, negative regulation of endocytosis, negative regulation of cellular component organization and so on, 26 genes were annotated in cell component (CC) branch these genes are related to cell soma, lysosomes and lytic vacuole, which indicates that cellular components involved in the development and progression of autoimmune diseases, and 23 genes in molecular function (MF) branch are related with peptidase activity, which suggests that the mechanism of pathology of autoimmune diseases may related to the activity of peptidases *in vivo* (Table [4](#T4){ref-type="table"}).

Mining shared pathways and GO terms of the four diseases {#s2_3}
--------------------------------------------------------

We used DAVID to annotate four related-disease genes on GO and KEGG. The results show 59 shared terms containing 33 in BP branch, 22 in CC branch and 4 in MF branch (Table [5](#T5){ref-type="table"}), which involve RNA processing, phosphorus metabolic process, phosphate metabolic process, apoptosis, humoral immune response, cell cycle, regulation of protein kinase cascade, regulation of cell death, positive regulation of cell death, programmed cell death, phosphorylation, regulation of protein modification process, positive regulation of protein modification process, regulation of cellular protein metabolic process, negative regulation of cellular protein metabolic process, positive regulation of cellular protein metabolic process, ncRNA processing, regulation of phosphorylation, regulation of apoptosis, positive regulation of apoptosis, regulation of programmed cell death, positive regulation of programmed cell death, positive regulation of catalytic activity, positive regulation of molecular function, innate immune response, positive regulation of protein kinase activity, regulation of binding, regulation of DNA binding, positive regulation of protein metabolic process, negative regulation of protein metabolic process, positive regulation of transferase activity, regulation of cell cycle, macromolecular complex assembly, nucleotide binding, protein kinase activity, enzyme binding, protein dimerization activity, cell fraction, lytic vacuole, nucleoplasm, nucleolus, mitochondrion, mitochondrial envelope, lysosome, vacuole, cytosol, cytoplasmic membrane-bounded vesicle, cytoplasmic vesicle, organelle envelope, membrane-enclosed lumen, envelope, nuclear lumen, vesicle, membrane-bounded vesicle, melanosome, organelle lumen, mitochondrial part, pigment granule and intracellular organelle lumen. It suggests that abnormal DNA transcription, RNA translation and non-coding RNA regulation join in apoptosis, cell cycle and other biological processes or mitochondria, lysosomes and other cell components, and the body's innate immune response and immune response that are caused by body's metabolism changing that lead by abnormal cell and processes abnormal, and eventually cause disease.

We analyzed four disease pathways and discovery that there are 2 shared pathways associated with four diseases, 2 pathways are associated with three diseases, and nine pathways are associated with two diseases (Details in Table [6](#T6){ref-type="table"}). Lysosome (hsa04142) and Fc gamma R-mediated phagocytosis (hsa04666) pathways are shared four diseases, details in Figure [1](#F1){ref-type="fig"}. They combine with each other in function and participate in the formation of lysosomes and phagocytosis. Lysosomal pathway is the interactional relationship between enzyme and genes described in cells. Lysosomes are membrane-delimited organelles in animal cells and serve as main digestive compartment in which all kinds of macromolecules are delivered and depredated. Lysosomes contain more than 40 hydrolases in an acidic environment (pH of about 5). Lysosomes synthesize in the endoplasmic reticulum (ER), and they are decorated with mannose-6-phosphate residues that are recognized by mannose-6-phosphate receptors in the trans-Golgi network \[[@R15]\]. They are packaged into clathrin-coated vesicles and then they are transported to late endosomes. Lysosomes acquire substances for digestion *via* a series of processes including endocytosis, phagocytosis, and autophagy . Phagocytosis joins in lysosomal pathway \[[@R15]\]. Fc gamma R-mediated phagocytosis pathway is a phagocytosis involving Fcγ receptor in intracellular. Phagocytosis composites the host-defense mechanisms that infectious pathogens absorb and destroy \[[@R16]\]. In higher organisms, these special cells including macrophages, neutrophils and monocytes involved in phagocytosis which constitutes the cellular immune barrier . Fc gamma receptors recognize foreign extracellular materials after opsonization with antibodies (IgG). Cross-linking of Fc gamma receptors initiates a variety of signals that is mediated by tyrosine phosphorylation of multiple proteins, which lead to the formation of phagosomes through the actin cytoskeleton rearrangements and membrane remodeling . Undergoing fusion with lysosomes, nascent phagosomes begin to become maturation. The acquisition of lysosomal proteases and release of reactive oxygen are crucial for digestion and degradation of engulfed materials in phagosomes . Phagocytosis conjunct with the lysosomes and ultimately exert their role, the two processes are complement and support each other mutually but indispensable, both of which acceleration and interaction with each other. In summary, they are associated with lysosomes: lysosomal pathway is a process lysosome degrades macromolecules in a cell by phagocytosis. While Fc gamma R-mediated phagocytosis pathway is that phagosomes formed Fc gamma receptor recognize antibody combine with lysosomes and activates; they are important ways to immune system playing. It implies that autoimmune diseases pathology is most likely the change to transcription and translation of genes associated with the lysosomes and Fcγ receptor in the body \[[@R16]\], and phagocytosis of immune system attack the body's itself, which lead to tissues or systemic damage and eventually generate disease. Variation of involving genes has been increased by environmental factors, which caused the epigenetic regulation factor including non-coding RNA to change that caused transcription and translation of their regulatory target genes (autoimmune disease-related genes) to change, and then caused disease. We discovered that lysosomes are shared GO terms, which it shows lysosomes are important organelles involving the four kinds of autoimmune diseases, and the lysosome-associated genes involve din the development and progression of them.

![The shared pathways on four autoimmune diseases\
**A.** Lysosome pathway, **B.** Fc gamma R-mediated phagocytosis, red indicates disease-related genes.](oncotarget-08-108355-g001){#F1}

MS. RA and SLE shared the ribosome pathway (Figure [2](#F2){ref-type="fig"}). Ribosome is an essential organelle for translating and processing genetic information. It is a particle that composed of RNA and protein, and a lot of them exist in all active protein synthesis cells. Ribosome contains two subunits, formula weight of the large subunit is twice as the small, and their weights are about 60% of RNA. The small subunit determines the protein sequences constituting interactions mediated mRNA and tRNA, while the large catalyzes peptide bond formation. Aminoacyl tRNA (aa-tRNA) and peptidyl tRNA (p-tRNA) are substrate catalyzed large subunit, the former is bound to A-site in ribosome and the other combined P-site, α-amino group of AA-tRNA encountered 3 'hydroxyl carbon of carbonyl-acylated peptidyl -tRNA and formed on tetrahedral carbonyl carbon. Tetrahedral core is amino acids extending peptide, in which A-site is binding esterified tRNA and P binding deacylated tRNA, and then the new replacement of aa-tRNA and p-tRNA continue to extend \[[@R17]\]. The pathway involving in protein synthesis suggests that three diseases including MS, RA and SLE are related to ribosome synthesizing protein.

![The shared ribosome pathway on MS\
RA and SLE, red indicates disease-related genes.](oncotarget-08-108355-g002){#F2}

T1D, MS and RA shared Pathogenic *Escherichia coli* infection pathway. Pathogenic *Escherichia coli* contain Enteropathogenic *E. coli* (EPEC) and enterohemorrhagic *E. coli* (EHEC) in pathway (Figure [3](#F3){ref-type="fig"}), they are closely related to pathogenic strains of *Escherichia coli*. The hallmark of EPEC/EHEC infections is an induction of damaging intestinal epithelial cells by attaching and effacing (A/E) lesions. The locus of enterocyte effacement (LEE) Pathogenicity Island encodes protein that is the capacity to form A/E lesions. Tir, Map, EspF and EspG are all LEE-encoded effector proteins secreted through the type III secretion system, which is also LEE-encoded into the host cell \[[@R18]\]. EPEC and EHEC Tir link the extracellular bacterium to the cell cytoskeleton, Map and EspF involve membrane permeabilization in mitochondrion \[[@R18]\]. EspG activates with tubulins and then stimulates microtubule destabilization. LEE-encoded adhesin or intimin (Eae) is exported through the general secretory pathway to the periplasm, where it is inserted into the outer membrane \[[@R19]\]. In addition to Tir, two potential host cell-carried intimin receptors, beta1 integrin (ITGB1) and nucleolin (NCL), have been identified so far. The remarkable feature of EHEC is the elaboration of Shiga-like toxin (Stx). Stx cleaves ribosomal RNA (rRNA), thereby disrupting protein synthesis and killing the intoxicated epithelial or endothelial cells. The pathway disrupting protein synthesis suggests that the development of three diseases including T1D, MS and RA is closely related to protein of pathway interference.

![The shared pathogenic *Escherichia coli* infection pathway on T1D, MS and RA\
Red indicates disease-related genes.](oncotarget-08-108355-g003){#F3}

The chronic myeloid leukemia pathway is shared by T1D and MS, the oxidative phosphorylation pathway is shared by MS and SLE, neurotrophin signaling pathway is shared by MS and RA, and chemokine signaling pathway, adherens junction pathway, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity pathway, T cell receptor signaling pathway and leukocyte transendothelial migration pathway are shared by RA and SLE. For example, toll-like receptor signaling pathway (Figure [4](#F4){ref-type="fig"}) is shared by RA and SLE, in which toll-like receptors (TLRs) is a specific pattern recognition receptor \[[@R20]\]. Specific families of pattern recognition receptors are used to detecting microbial pathogens and generating innate immune responses. Mammalian TLRs are expressed on innate immune cells including macrophages and dendritic cells, and reaction the membrane components of Gram-positive or Gram-negative bacteria \[[@R21]\]. TLRs recognition pathogen provokes rapidly activation of innate immunity based on inducing production of proinflammatory cytokines and upregulation of costimulatory molecules \[[@R21]\]. TLR signaling pathway is divided into two groups: a MyD88-dependent pathway that lead to be rapid activate NFκB and MAPK by the production of proinflammatory cytokines, and the other MyD88-independent pathway is associated with the induction of IFN-beta and IFN-inducible genes, and slow activation of NFκB and MAPK by maturation of dendritic cells \[[@R20]\]. The pathway has an effect on the activated process of NFκB and MAPK which is divided into two kinds of rapid and slow activation pathway, while RA and SLE is characterized by the acute onset and the long-term chronic cumulative which inducing tissue damage \[[@R22]\]. It indicates that the occurrence and development of RA and SLE are closely related with pathway and genes and cytokine in pathway.

![The shared toll-like receptor signaling pathway on RA and SLE, red indicates disease-related genes](oncotarget-08-108355-g004){#F4}

The shared GO terms and KEGG pathways may provide a more valuable reference and basis for studying pathogenesis of autoimmune diseases.

Mining specific pathways of the four autoimmune diseases {#s2_4}
--------------------------------------------------------

We discovered 34 specific pathways, for T1D is 9, MS is 9, RA is 10 and SLE is 6(detailed in Table [7](#T7){ref-type="table"}-[10](#T10){ref-type="table"}). 19 of them have literature confirmation that they are related to the four diseases, in particular 9 specific pathways were found for T1D, among which 6 pathways have been confirmed related with SLE.

There are 9 pathways related with T1D including histidine metabolism, glutathione metabolism, other glycan degradation, spliceosome, endocytosis, TGF-beta signaling pathway, insulin signaling pathway, GnRH signaling pathway and Vibrio cholerae infection(Table [7](#T7){ref-type="table"}). Recent research has confirmed 6 pathways related with T1D, including histidine metabolism, glutathione metabolism, spliceosome, TGF-β signaling pathway, insulin signaling pathway and Vibrio cholerae infection. As an example to insulin signaling pathway (Figure [5A](#F5){ref-type="fig"}), which is binding insulin with receptor what makes insulin receptor substrate (IRS) occurring tyrosine phosphorylation by tyrosine kinase (INSR). This allows IRSs associated with the regulatory subunit of phosphoinositide 3-kinase (PI3K), and then PI3K activates 3-phosphoinositide-dependent protein kinase 1 (PDK1), which activates a serine kinase (Akt). In turn, Akt deactivates glycogen synthase kinase 3 (GSK-3), which leads to activation of glycogen synthase (GYS) and thus synthesizes glycogen. Activation of Akt also makes GLUT4 vesicles translocate from their intracellular pool to the plasma membrane, where glucose is allowed uptake into the cell. Akt also leads to activate the protein synthesis with mTOR-mediated by eIF4 and p70S6K \[[@R23]\]. The translocation of GLUT4 protein makes the CAP/Cbl/TC10 pathway elicite, once Cbl is phosphorylated by INSR. Other signal transduction proteins including GRB2 activate with IRS, which is part of the cascade including SOS, RAS, RAF and MEK that leads to mitogen-activated protein kinase (MAPK) activating and mitogenic responding in the form of gene transcription \[[@R23]\]. SHC is another substrate of INSR. When tyrosine phosphorylated, SHC may associate with GRB2 and thus activate the RAS/MAPK pathway of IRS-1 independently. The pathway increases in involving in glucose metabolism and controlling blood sugar levels in the body's, and it is closely related with T1D. Insulin signaling pathway is the special characteristic of diabetes, diabetes is characterized by the body producing insulin abnormally, and diabetes patients also have a speed disorder of their body, which may be related to hormonal signal transduction pathway that leading to hormone levels abnormal. In addition, we predicted 3 pathways including other glycan degradation, endocytosis and GnRH signaling pathway related to T1D, wherein the GnRH signaling pathway (Figure [5B](#F5){ref-type="fig"}) is a process that Gonadotropin-releasing hormone (GnRH) secreting from the hypothalamus acts upon its receptor in the anterior pituitary and increases the production and releases the gonadotropins containing LH and FSH \[[@R24]\]. The GnRHR coupled to Gq/11 proteins activates phospholipase C which transmits its signal to diacylglycerol (DAG) and inositol 1, 4, 5-trisphosphate (IP3) \[[@R24]\]. DAG can activate the intracellular protein kinase C (PKC) pathway and IP3 can stimulate release of intracellular calcium. Occasionally, coupling of Gs except the classical Gq/11 is observed in a cell-specific fashion. Signaling downstream of PKC transactives the epidermal growth factor (EGF) receptor and actives mitogen-activated protein kinases (MAPKs), including extracellular-signal-regulated kinase (ERK), Jun N-terminal kinase (JNK) and p38 MAPK. Active MAPKs transfer into the nucleus, resulting in activating transcription factors and rapidly inducting early genes \[[@R25]\].

![The special pathways of T1D, red indicates disease-related genes\
**A.** Insulin signaling pathway, **B.** GnRH signaling pathway.](oncotarget-08-108355-g005){#F5}

There are 9 pathways related to MS, containing fructose and mannose metabolism, glycosaminoglycan degradation, proteasome, ErbB signaling pathway, mTOR signaling pathway, Alzheimer's disease, Parkinson's disease, Huntington's disease and renal cell carcinoma (Table [8](#T8){ref-type="table"}). Most of these pathways involve in the body's nerves regulating and regulation \[[@R26]\], in which six are confirmed MS-related by literatures, including the proteasome, mTOR signaling pathway, Alzheimer's disease, Parkinson's disease, Huntington's disease and renal cell carcinoma pathway. As an example, proteasome pathway is the main pathway that proteases activated in the body. Proteasome is a complex degrading protein in Figure [6A](#F6){ref-type="fig"}, which involves in many essential cellular functions, such as regulation of cell cycle, cell differentiation, apoptosis, signal transduction pathways, antigen processing for appropriate immune responses, stress signaling, and inflammatory responses . It is in a rapid and timely fashion that proteasome degrades a variety of cellular proteins and most substrate proteins are modified by ubiquitin before their degraded by the proteasome. PA200 has been identified as a large nuclear protein stimulating proteasomal hydrolysis of peptides \[[@R27]\]. The other three have not been confirmed associated with MS, there they are predicted for the first time, including fructose and mannose metabolism, glycosaminoglycan degradation and ErbB signaling pathway. ErbB signaling pathway stimulates diverse biologic responses that ErbB family of receptor tyrosine kinases (RTKs) couples binding extracellular growth factor ligands to intracellular signaling pathways (Figure [6B](#F6){ref-type="fig"}), which includes proliferation, differentiation, cell motility and survival. Ligand binding to the four closely related members of RTK family, epidermal growth factor receptor (EGFR, also known as ErbB-1 or HER1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4), induces forming receptor homo- and heterodimers and actives intrinsic kinase domain, and then results in phosphorylation on specific tyrosine residues (pY) within the cytoplasmic tail . The Shc- and/or Grb2-activated mitogen-activated protein kinase (MAPK) pathway is a shared target downstream of all ErbB receptors \[[@R28]\]. Similarly, the phosphatidylinositol-3-kinase (PI-3K) pathway is directly or indirectly activated by most of ErbBs \[[@R28]\]. Several cytoplasmic docking proteins seem to be exploited by specific ErbB receptors and less by others . We found that these specific pathways of our research are involved in an important factor of MS development. More interesting, there are three pathways containing Alzheimer's disease, Parkinson's disease, and Huntington's disease are involved in MS and other three neurological diseases. The results imply that MS is closely related with Alzheimer's disease, Parkinson's disease and Huntington's disease.

![The special pathways of MS, red indicates disease-related genes\
**A.** Proteasome, **B.** ErbB signaling pathway.](oncotarget-08-108355-g006){#F6}

There are 10 pathways associated with RA (Table [9](#T9){ref-type="table"}), containing cysteine and methionine metabolism, cytokine-cytokine receptor interaction, apoptosis, hematopoietic cell lineage, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, and intestinal immune network for IgA production, circadian rhythm, prion diseases and primary immunodeficiency. Previous researches have demonstrated four pathways associated with RA including apoptosis, B cell receptor signaling pathways, circadian rhythm and primary immunodeficiency. Apoptosis pathway is a genetically programmed process to eliminate damaged or redundant cells by caspases (aspartate-specific cysteine proteases) activing (Figure [7A](#F7){ref-type="fig"}). The occurrence of apoptosis is controlled by numerous interrelating processes \[[@R29]\]. The 'extrinsic' pathway involves in stimulating members of tumor necrosis factor (TNF) receptor subfamily, such as TNFRI, CD95/Fas or TRAILR (death receptors) which locate on the cell surface, by their specific ligands such as TNF-alpha, FasL or TRAIL, respectively \[[@R29]\]. The 'intrinsic' pathway is activated mainly by non-receptor stimuli that containing DNA damage, ER stress, metabolic stress, UV radiation or growth-factor deprivation \[[@R29]\]. The central event of the 'intrinsic' pathway is the mitochondrial outer membrane permeabilization (MOMP), and then leads to the release of cytochrome C. These two pathways converge at the level of effector caspases for instance caspase-3 and caspase-7. The constituents of cytotoxic (e.g. Perforin and Granzyme B) granules initiates the third major pathways that are released by CTLs (cytotoxic T-cells) and NK (natural killer) cells. Granzyme B is similar to the caspases cleaves its substrates after aspartic acid residues, which suggests that this protease has been able to activate members of the caspase family directly. The balance between the pro- and anti-apoptotic signals eventually determines whether cells will undergo apoptosis, survive or proliferate. We predicted 6 pathways related with RA, including cysteine and methionine metabolism, cytokine-cytokine receptor interaction, hematopoietic cell lineage, Fc epsilon RI signaling pathway, intestinal immune network for IgA production, and Prion diseases. We found that one of RA-related pathways - prion diseases pathway, is a caused process of body reaction by prions in Figure [7B](#F7){ref-type="fig"}. Prion diseases, also called transmissible spongiform encephalopathies (TSEs), are a series of fatal neurodegenerative diseases that have an effect on humans and a number of other animal species. The etiology of them is considered to be associated with converting a normal protein PrPC into an infectious pathogenic form PrPSc. The conversion is induced by prion infections (for example, variant Creutzfeldt-Jakob disease (vCJD), iatrogenic CJD, Kuru), mutations (familial CJD, Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia (FFI)) or unknown factors (sporadic CJD (sCJD)), and it is considered to occur after PrPC has reached the plasma membrane or has been re-internalized for degradation \[[@R30]\]. The PrPSc form shows greater protease resistance than PrPC, which accumulates in affected individuals and often in the form of extracellular plaques \[[@R31]\]. Pathways lead to neuronal death comprise oxidative stress, corticosteroid response, endoplasmic reticulum stress, regulated activation of complement, ubiquitin-proteasome and endosomal-lysosomal systems, synaptic alterations and dendritic atrophy \[[@R31]\]. In addition, the conformational transition could lead to loss of a beneficial activity that protein PrPC is the natively folded \[[@R31]\]. It is more interesting that the specific pathways of RA are related with circadian rhythm, which suggests that the occurrence of RA is closely related to environmental factors. The findings provide a better and more effective ways to prevent the development and progression of RA.

![The special pathways on RA, red indicates disease-related genes\
**A.** Apoptosis, **B.** Prion diseases.](oncotarget-08-108355-g007){#F7}

There are 6 SLE specific pathways (Table [10](#T10){ref-type="table"}), containing MAPK signaling pathway, calcium signaling pathway, renin-angiotensin system, RIG-I-like receptor signaling pathway, cytosolic DNA-sensing pathway and prostate cancer, they are signal pathways involved in regulating systemic and systemic vascular regulation, and these features are coincided with characteristics occurring SLE systemic. There are 3 of them confirmed they are related to SLE by literatures, including calcium signaling pathway, renin-angiotensin system and prostate cancer. For example renin-angiotensin system (RAS) is a peptidergic system with endocrine regulation of the blood pressure and hydro-electrolytic balance (Figure [8A](#F8){ref-type="fig"}). In the classical RAS, the enzyme renin cleaves its substrate angiotensinogen (Agt), and it is forming the decapeptide angiotensin I that is cleaved by angiotensin-converting enzyme (ACE) and produces the angiotensin II (Ang II) in turn, which is a key player of this system \[[@R32]\]. Ang II activates its AT1 receptor (AT1R), the mainly receptor mediates the majority of Ang II as known actions in the kidney including vasoconstriction, renal sodium (Na+) reabsorption, and aldosterone secretion, increasing blood pressure and contributing to the development of hypertension. In addition to (ACE)/Ang II/AT1R and AT2R axis, other signaling pathways in the RAS( such as ACE2/angiotensin-(1-7)/Mas and Ang IV/IRAP), and other active peptide of the RAS(physiological relevance as Ang III, Ang A and alamandine), are now also widely recognized \[[@R33]\]. RAS is a pathway with systemic impact, which activates the body's water and electrolyte regulation. This means that the pathogenesis of SLE is associated with RAS. Furthermore, we also firstly observed MAPK signaling pathway, RIG-I-like receptor signaling pathway and cytosolic DNA-sensing pathway with SLE-related. Among them, cytosolic DNA-sensing pathway has an effect on systemic pathway (Figure [8B](#F8){ref-type="fig"}), and it is innate immune responses generated that specific families of pattern recognition receptors are responsible for detecting foreign DNA from invading microbes or host cells . DAI is the first sensor identified cytosolic DNA which activates the IRF and NF $\kappa$ B transcription factors and leads to production of type I interferon and other cytokines. AIM2 is also a type of cytoplasmic DNA sensor. Upon sensing DNA, AIM2 triggers off assembling inflammasome, and culminates in interleukin maturation. In addition, to these receptors there is a mechanism to sense foreign DNA with the host RNA polymerase III converting the DNA into RNA recognized by the RNA sensor RIG-I \[[@R34]\]. These pathways alert the cell through various means, and are closely related with SLE.

![The special pathways of SLE, red indicates disease-related genes\
**A.** Renin-angiotensin system, **B.** Cytosolic DNA-sensing pathway.](oncotarget-08-108355-g008){#F8}

In brief, the specific pathways provide theoretical basis and reference of understanding specific phenotypes and mechanisms.

DISCUSSION {#s3}
==========

Our research explored the shared and special mechanisms of four common autoimmune diseases including T1D, MS, RA and SLE. Their occurrences are result from abnormal immune system that antibodies attacks normal tissues lead to damaged tissues and organs, these four diseases acquire some shared features that maybe also shared some features of autoimmune diseases. The shared features may be controlled by their shared genes and pathways. They also have their own specific related genes and pathways. When they occur as abnormalities, those diseases will appear disease-specific clinical phenotype.

This research used four different types function data (mRNA expression profile, SNP, methylation, microRNA expression profile), to study the shared and specific mechanisms of four autoimmune diseases from genetics and epigenetics. The purpose of this research is studying how miRNA and methylation regulate its target SNP and mRNA expression by the four different levels data, which affects the body's normal pathways access connectivity change and produce disease. We discover that there are 2 shared pathways associated with four diseases, including Lysosome (hsa04142) and Fc gamma R-mediated phagocytosis (hsa04666), and they are closely linked with each other. When lysosomes is formatting, the phagocytosis plays a necessary role, and contrarily phagocytosis results in forming lysosomes. That is illustrated that the occurrence and development of these four autoimmune diseases may be associated with lysosomes and phagocytosis. Since the genes that are controlling both pathways is influenced by genetic and environmental factors, cell lysosomes and phagocytosis have emerged abnormal in immune-related reaction, and then brought autoimmune diseases. At the same time, we also found 33 shared four disease-related genes, which are respectively annotated on GO and KEGG and found most of them are involving in immune system adjustment and response. It suggests that the change of expression and regulation cause transcription and translation, which is the important reason for causing the autoimmune diseases. The result makes pathogenesis and common mechanisms of autoimmune diseases take a forward step. Also, we found that T1D-related specific pathways were 9, MS is also 9, RA and SLE is 10 and 6 respectively. These pathways represent specific characteristics of their related to diseases, and so reveal specific mechanisms of the four diseases.

In our study, we carried out different test to genes or probes on the relation between probes and corresponding genes. In order to reduce the false positive rate and to improve the accuracy of the experiment as much as possible, we conducted a rigorous BH corrected and selected higher threshold, through which the genes are related to disease. While sample size is small , *T*-test is not siuitable, we can use fold-change to measure the differences and also adopt high standards as above for screening differences resulting in unified the number of different genes with each study. We used a larger number of samples, which is more widespread phenomenon, and then those special studies impact is not particularly serious on the overall. Our research methods ensure the results robust.

MATERIALS AND METHODS {#s4}
=====================

Data {#s4_1}
----

The expression, methylation and miRNA expression data used in this research were download from GEO database, which were acquired by searching keywords of the four diseases \[Rheumatoid Arthritis, Multiple Sclerosis, Systemic Lupus Erythematosus, Diabetes Mellitus Type 1\] and then the original data were filtered: the case-control data of T1D have 10 groups including one methylation, and 9 mRNA expression profiling of six different platforms, details in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}; the case-control data of MS have 23 groups including one methylation, 16 mRNA expression profiling of 9 different platforms, and 6 miRNA expression profiling of 5 platforms, details in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}; the case-control data of RA have 23 groups including two methylation of two platforms, 17 mRNA expression profiling of 14 different platforms, 5 miRNA expression profiling of 5 platforms, details in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}; the case-control data of SLE have 18 groups including two methylation of two platforms, 14 mRNA expression profiling of 9 different platforms, 2 miRNA expression profiling of 2 platforms, details in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}. The case-control sample data used in this research totally contain 70 groups of 36 different platforms, and the data statistics of the three different types on these four diseases are shown in Table [1](#T1){ref-type="table"}. Among these data, the data size of MS and RA are larger than the others, and expression profiles is the most studied in the three types of data.

###### The quantity of researches on the three types' data (methylation, expression and miRNA) related to the four diseases

  Disease   Methylation   Expression   miRNA
  --------- ------------- ------------ -------
  T1D       1             9            0
  MS        1             16           6
  RA        2             16           5
  SLE       2             14           2

RA : Rheumatoid Arthritics, MS : Multiple Sclerosis, SLE : Systemic Lupus Erythematosus, T1D : Type: Diabetes, miRNA: microRNA

###### The number of different genes of four diseases

  Disease   T1D    MS     RA     SLE
  --------- ------ ------ ------ ------
  Genes     1411   4946   4613   4201

###### The shared genes related to the four diseases

  GENE_SYMBOL   GENE_NAME                                                                             SPECIES
  ------------- ------------------------------------------------------------------------------------- --------------
  ARPC5L        actin related protein 2/3 complex, subunit 5-like                                     Homo sapiens
  B2M           beta-2-microglobulin                                                                  Homo sapiens
  C20orf24      chromosome 20 open reading frame 24                                                   Homo sapiens
  CCDC127       coiled-coil domain containing 127                                                     Homo sapiens
  CDC25B        cell division cycle 25 homolog B (S. pombe)                                           Homo sapiens
  CLEC10A       C-type lectin domain family 10, member A                                              Homo sapiens
  CLPP          ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog (*E. coli*)   Homo sapiens
  CTSZ          cathepsin Z                                                                           Homo sapiens
  CYBA          cytochrome b-245, alpha polypeptide                                                   Homo sapiens
  DNAJB11       DnaJ (Hsp40) homolog, subfamily B, member 11                                          Homo sapiens
  EEF1G         eukaryotic translation elongation factor 1 gamma                                      Homo sapiens
  EPHB2         EPH receptor B2                                                                       Homo sapiens
  FEM1C         fem-1 homolog c (C. elegans)                                                          Homo sapiens
  GGH           gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)                Homo sapiens
  KIAA1967      KIAA1967                                                                              Homo sapiens
  MAN2B1        mannosidase, alpha, class 2B, member 1                                                Homo sapiens
  MARCH1        membrane-associated ring finger (C3HC4) 1                                             Homo sapiens
  MICU1         mitochondrial calcium uptake 1                                                        Homo sapiens
  MIF           macrophage migration inhibitory factor (glycosylation-inhibiting factor)              Homo sapiens
  MRAS          muscle RAS oncogene homolog                                                           Homo sapiens
  NR1H3         nuclear receptor subfamily 1, group H, member 3                                       Homo sapiens
  NXT1          NTF2-like export factor 1                                                             Homo sapiens
  PDCD7         programmed cell death 7                                                               Homo sapiens
  PGAM1         phosphoglycerate mutase 1 (brain)                                                     Homo sapiens
  PPDPF         pancreatic progenitor cell differentiation and proliferation factor                   Homo sapiens
  PREPL         prolyl endopeptidase-like                                                             Homo sapiens
  RNASET2       ribonuclease T2                                                                       Homo sapiens
  RWDD1         RWD domain containing 1-like 1; RWD domain containing 1                               Homo sapiens
  SDF2L1        stromal cell-derived factor 2-like 1                                                  Homo sapiens
  SLC43A1       solute carrier family 43, member 1                                                    Homo sapiens
  TGFB1         transforming growth factor, beta 1                                                    Homo sapiens
  TREM2         triggering receptor expressed on myeloid cells 2                                      Homo sapiens
  ZP3           zona pellucida glycoprotein 3 (sperm receptor)                                        Homo sapiens

###### The shared genes annotating GO terms

  Category        Term                                                                *P* Value
  --------------- ------------------------------------------------------------------- -----------
  GOTERM_BP_FAT   GO:0006955∼immune response                                          0.009161
  GOTERM_BP_FAT   GO:0045730∼respiratory burst                                        0.02471
  GOTERM_BP_FAT   GO:0045806∼negative regulation of endocytosis                       0.028459
  GOTERM_BP_FAT   GO:0045087∼innate immune response                                   0.028615
  GOTERM_BP_FAT   GO:0051129∼negative regulation of cellular component organization   0.030163
  GOTERM_BP_FAT   GO:0006611∼protein export from nucleus                              0.034057
  GOTERM_BP_FAT   GO:0048610∼reproductive cellular process                            0.038386
  GOTERM_BP_FAT   GO:0009057∼macromolecule catabolic process                          0.059937
  GOTERM_BP_FAT   GO:0045596∼negative regulation of cell differentiation              0.064192
  GOTERM_BP_FAT   GO:0050768∼negative regulation of neurogenesis                      0.083059
  GOTERM_BP_FAT   GO:0045834∼positive regulation of lipid metabolic process           0.084827
  GOTERM_BP_FAT   GO:0010721∼negative regulation of cell development                  0.088353
  GOTERM_BP_FAT   GO:0002706∼regulation of lymphocyte mediated immunity               0.098855
  GOTERM_CC_FAT   GO:0043025∼cell soma                                                0.042278
  GOTERM_CC_FAT   GO:0005764∼lysosome                                                 0.063472
  GOTERM_CC_FAT   GO:0000323∼lytic vacuole                                            0.063472
  GOTERM_CC_FAT   GO:0005773∼vacuole                                                  0.086351
  GOTERM_MF_FAT   GO:0070011∼peptidase activity, acting on L-amino acid peptides      0.056796
  GOTERM_MF_FAT   GO:0008233∼peptidase activity                                       0.063278

There are 13, 4 and 2 terms in BP, CC and MF respectively, which the number of genes is greater than 2. 7 of 13 BP's terms and 1 of 4 CC's terms are significantly enrichment.

###### The shared genes in GO terms

  Category    GO_TermID    GO_annotation
  ----------- ------------ -----------------------------------------------------------
  GOTERM_BP   GO:0006396   RNA processing
  GOTERM_BP   GO:0006793   phosphorus metabolic process
  GOTERM_BP   GO:0006796   phosphate metabolic process
  GOTERM_BP   GO:0006915   apoptosis
  GOTERM_BP   GO:0006959   humoral immune response
  GOTERM_BP   GO:0007049   cell cycle
  GOTERM_BP   GO:0010627   regulation of protein kinase cascade
  GOTERM_BP   GO:0010941   regulation of cell death
  GOTERM_BP   GO:0010942   positive regulation of cell death
  GOTERM_BP   GO:0012501   programmed cell death
  GOTERM_BP   GO:0016310   phosphorylation
  GOTERM_BP   GO:0031399   regulation of protein modification process
  GOTERM_BP   GO:0031401   positive regulation of protein modification process
  GOTERM_BP   GO:0032268   regulation of cellular protein metabolic process
  GOTERM_BP   GO:0032269   negative regulation of cellular protein metabolic process
  GOTERM_BP   GO:0032270   positive regulation of cellular protein metabolic process
  GOTERM_BP   GO:0034470   ncRNA processing
  GOTERM_BP   GO:0042325   regulation of phosphorylation
  GOTERM_BP   GO:0042981   regulation of apoptosis
  GOTERM_BP   GO:0043065   positive regulation of apoptosis
  GOTERM_BP   GO:0043067   regulation of programmed cell death
  GOTERM_BP   GO:0043068   positive regulation of programmed cell death
  GOTERM_BP   GO:0043085   positive regulation of catalytic activity
  GOTERM_BP   GO:0044093   positive regulation of molecular function
  GOTERM_BP   GO:0045087   innate immune response
  GOTERM_BP   GO:0045860   positive regulation of protein kinase activity
  GOTERM_BP   GO:0051098   regulation of binding
  GOTERM_BP   GO:0051101   regulation of DNA binding
  GOTERM_BP   GO:0051247   positive regulation of protein metabolic process
  GOTERM_BP   GO:0051248   negative regulation of protein metabolic process
  GOTERM_BP   GO:0051347   positive regulation of transferase activity
  GOTERM_BP   GO:0051726   regulation of cell cycle
  GOTERM_CC   GO:0065003   macromolecular complex assembly
  GOTERM_CC   GO:0000166   nucleotide binding
  GOTERM_CC   GO:0004672   protein kinase activity
  GOTERM_CC   GO:0019899   enzyme binding
  GOTERM_CC   GO:0046983   protein dimerization activity
  GOTERM_CC   GO:0000267   cell fraction
  GOTERM_CC   GO:0000323   lytic vacuole
  GOTERM_CC   GO:0005654   nucleoplasm
  GOTERM_CC   GO:0005730   nucleolus
  GOTERM_CC   GO:0005739   mitochondrion
  GOTERM_CC   GO:0005740   mitochondrial envelope
  GOTERM_CC   GO:0005764   lysosome
  GOTERM_CC   GO:0005773   vacuole
  GOTERM_CC   GO:0005829   cytosol
  GOTERM_CC   GO:0016023   cytoplasmic membrane-bounded vesicle
  GOTERM_CC   GO:0031410   cytoplasmic vesicle
  GOTERM_CC   GO:0031967   organelle envelope
  GOTERM_CC   GO:0031974   membrane-enclosed lumen
  GOTERM_CC   GO:0031975   envelope
  GOTERM_CC   GO:0031981   nuclear lumen
  GOTERM_CC   GO:0031982   vesicle
  GOTERM_CC   GO:0031988   membrane-bounded vesicle
  GOTERM_CC   GO:0042470   melanosome
  GOTERM_MF   GO:0043233   organelle lumen
  GOTERM_MF   GO:0044429   mitochondrial part
  GOTERM_MF   GO:0048770   pigment granule
  GOTERM_MF   GO:0070013   intracellular organelle lumen

###### The four diseases-related pathways

  Disease                                            T1D                                                MS                                                   RA                                                   SLE
  -------------------------------------------------- -------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- -------------------
  pathway                                            hsa04142:Lysosome                                  hsa04142:Lysosome                                    hsa04142:Lysosome                                    hsa04142:Lysosome
  hsa04666:Fc gamma R-mediated phagocytosis          hsa04666:Fc gamma R-mediated phagocytosis          hsa04666:Fc gamma R-mediated phagocytosis            hsa04666:Fc gamma R-mediated phagocytosis            
                                                     hsa03010:Ribosome                                  hsa03010:Ribosome                                    hsa03010:Ribosome                                    
  hsa05130:Pathogenic *Escherichia coli* infection   hsa05130:Pathogenic *Escherichia coli* infection   hsa05130:Pathogenic *Escherichia coli* infection                                                          
  hsa05220:Chronic myeloid leukemia                  hsa05220:Chronic myeloid leukemia                                                                                                                            
                                                     hsa00190:Oxidative phosphorylation                                                                      hsa00190:Oxidative phosphorylation                   
                                                                                                        hsa04062:Chemokine signaling pathway                 hsa04062:Chemokine signaling pathway                 
                                                                                                        hsa04520:Adherens junction                           hsa04520:Adherens junction                           
                                                                                                        hsa04620:Toll-like receptor signaling pathway        hsa04620:Toll-like receptor signaling pathway        
                                                                                                        hsa04650:Natural killer cell mediated cytotoxicity   hsa04650:Natural killer cell mediated cytotoxicity   
                                                                                                        hsa04660:T cell receptor signaling pathway           hsa04660:T cell receptor signaling pathway           
                                                                                                        hsa04670:Leukocyte transendothelial migration        hsa04670:Leukocyte transendothelial migration        
                                                     hsa04722:Neurotrophin signaling pathway            hsa04722:Neurotrophin signaling pathway                                                                   

###### The special pathways on T1D

  Disease   ID   KEGG_pathway                          Certified
  --------- ---- ------------------------------------- -----------
  T1D       1    hsa00340:Histidine metabolism         \*
  T1D       2    hsa00480:Glutathione metabolism       \*
  T1D       3    hsa00511:Other glycan degradation     
  T1D       4    hsa03040:Spliceosome                  \*
  T1D       5    hsa04144:Endocytosis                  
  T1D       6    hsa04350:TGF-beta signaling pathway   \*
  T1D       7    hsa04910:Insulin signaling pathway    \*
  T1D       8    hsa04912:GnRH signaling pathway       
  T1D       9    hsa05110:Vibrio cholerae infection    \*

\*: The pathways that are certified associated with T1D by papers

###### The special pathways of MS

  Disease   ID   KEGG_pathway                               Certified
  --------- ---- ------------------------------------------ -----------
  MS        1    hsa00051:Fructose and mannose metabolism   
  MS        2    hsa00531:Glycosaminoglycan degradation     
  MS        3    hsa03050:Proteasome                        \*
  MS        4    hsa04012: ErbB signaling pathway           
  MS        5    hsa04150:mTOR signaling pathway            \*
  MS        6    hsa05010:Alzheimer\'s disease              \*
  MS        7    hsa05012:Parkinson\'s disease              \*
  MS        8    hsa05016:Huntington\'s disease             \*
  MS        9    hsa05211:Renal cell carcinoma              \*

\*: The pathways that are certified associated with MS by papers

###### The special pathways of RA

  Disease   ID   KEGG_pathway                                            Certified
  --------- ---- ------------------------------------------------------- -----------
  RA        1    hsa00270:Cysteine and methionine metabolism             
  RA        2    hsa04060:Cytokine-cytokine receptor interaction         
  RA        3    hsa04210:Apoptosis                                      \*
  RA        4    hsa04640:Hematopoietic cell lineage                     
  RA        5    hsa04662:B cell receptor signaling pathway              \*
  RA        6    hsa04664:Fc epsilon RI signaling pathway                
  RA        7    hsa04672:Intestinal immune network for IgA production   
  RA        8    hsa04710:Circadian rhythm                               \*
  RA        9    hsa05020:Prion diseases                                 
  RA        10   hsa05340:Primary immunodeficiency                       \*

\*: The pathways that are certified associated with RA by papers

###### The special pathways of SLE

  Disease   ID   KEGG_pathway                                     Certified
  --------- ---- ------------------------------------------------ -----------
  SLE       1    hsa04010:MAPK signaling pathway                  
  SLE       2    hsa04020:Calcium signaling pathway               \*
  SLE       3    hsa04614:Renin-angiotensin system                \*
  SLE       4    hsa04622:RIG-I-like receptor signaling pathway   
  SLE       5    hsa04623:Cytosolic DNA-sensing pathway           
  SLE       6    hsa05215:Prostate cancer                         \*

\*: The pathways that are certified associated with SLE by papers

Data procession and different genes filterion {#s4_2}
---------------------------------------------

Different types' data means different: mRNA expression profiling data is a direct reflection on expression of the gene itself, methylation regulating target genes methylation level near the location of methylated sites can reflect gene expression, while miRNA regulating RNA sequences can inhibit genes expression.

\(1\) Filterion of different genes based on methylation and gene expression profile

Firstly, we can map probes into genes according to annotated platform file and when a gene contains a plurality of probes, we calculated the average of probes to measure the expression level or methylation level of the gene. Then, we can analyze every case-control research of every disease to filter out significantly different genes. Here, for the case-control samples with size greater than 2 *T*-test and Benjamini-Hochberg (BH) correction (*q* \< 0.001) were used \[[@R10]\], and for the rest fold change method (FC \> 2) was used \[[@R11]\].

\(2\) Filterion of different miRNA and target genes based on miRNA

We analyzed each case-control data of miRNA and filtered four diseases related to the different miRNA by using *T*-test and BH correction (*q* \< 0.001) to the samples with size greater than 2 \[[@R10]\],and the rest through using fold change (FC \> 2) to filter out the significant difference of miRNA \[[@R11]\]. Then, we determined target genes that expressed different miRNA based on the regulatory relationship between miRNA and target genes in miRTarBase (<http://mirtarbase.mbc.nctu.edu.tw/>). Because the same gene may be inhibited by many miRNAs, the standard of target genes filtered out is the miRNAs regulating target genes are all significant different miRNA and then the gene is different related-disease gene.

We got four related-disease gene sets, which are used following to analyze.

Annotating GO and mining KEGG pathway based on the genes related to the four autoimmune diseases {#s4_3}
------------------------------------------------------------------------------------------------

We used online annotation tool DAVID for disease-related genes annotating of GO and KEGG \[[@R12]\]. We first analyzed and annotated the four related-disease genes, and discovered the shared genes, GO terms and KEGG pathways. Then we analyzed and discovered the specific GO terms and KEGG pathways related to the four disease genes.

SUPPLEMENTARY MATERIALS TABLES {#s5}
==============================
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T1D

:   Type 1 Diabetes Mellitus
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:   Multiple Sclerosis
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